SEC Form 4 · accession 0001078782-16-003844

VOLITIONRX LTD · VNRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Scientific Officer

Period of report

Nov 18, 2016

Accepted (ET)

Nov 21, 2016 · 4:20 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000093314

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Nov 18, 2016	M	20,000	$3.00	A	51,506	I	Borlaug Limited
Common Stock^F1,F2	Nov 18, 2016	F	13,393	$4.48	D	38,113	I	Borlaug Limited

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$3.00	Nov 18, 2016	M	20,000	D	Nov 25, 2012	Nov 25, 2016	Common Stock	20,000	0	I

F1Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction.
F2The shares of Common Stock are held directly by Borlaug Limited. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issued to Borlaug Limited upon the exercise of the Option. Dr. Micallef disclaims beneficial ownership of the shares of Common Stock issued upon exercise of the Option, except to the extent of his pecuniary interest.
F3The Option is held directly by Borlaug Limited. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issuable upon the exercise of the Option. Dr. Micallef disclaims beneficial ownership of the shares of Common Stock issuable upon the exercise of the Option, except to the extent of his pecuniary interest.